G1 Therapeutics Raises $105M In IPO Guided By Mintz Levin
By Jon Hill ( May 17, 2017, 2:13 PM EDT) -- Stock in G1 Therapeutics Inc. debuted on Wednesday after the venture capital-backed clinical-stage cancer treatment research company priced a $105 million initial public offering under guidance from Mintz Levin Cohn Ferris Glovsky and Popeo PC....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.